No Association between the R2 Factor V Gene and Acute Coronary Events

N. Ameziane; D. Lebret; A. Combe; M.-C. Aumont; D. de Prost

doi:10.1055/s-0037-1615628

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 85(03): 566-567
DOI: 10.1055/s-0037-1615628

Letters to the Editor

Schattauer GmbH

No Association between the R2 Factor V Gene and Acute Coronary Events

Autor*innen

N. Ameziane

¹Service d’Hématologie et d’Immunologie, Hôpital Louis Mourier, Colombes
D. Lebret

¹Service d’Hématologie et d’Immunologie, Hôpital Louis Mourier, Colombes
A. Combe

¹Service d’Hématologie et d’Immunologie, Hôpital Louis Mourier, Colombes
M.-C. Aumont

²Service de Cardiologie, Hôpital Bichat-Claude Bernard AP-HP, Paris, France
D. de Prost

¹Service d’Hématologie et d’Immunologie, Hôpital Louis Mourier, Colombes

Abstract

Volltext

Referenzen

References
1 Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Mannucci PM. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997; 90: 1552-7.
2 Lunghi B, Iacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F. Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma. Thromb Haemost 1996; 75: 45-8.
3 Castoldi E, Rosing J, Girelli D, Hoekema L, Lunghi B, Mingozzi F, Ferraresi P, Friso S, Corrocher R, Tans G, Bernardi F. Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma. Thromb Haemost 2000; 83: 362-5.
4 Castoldi E, Rosing J, Lunghi B, Hoekema L, Girelli D, Mingozzi F, Ferraresi P, Friso S, Corrocher R, Tans G, Bernardi F. Factor V gene mutations (R2 gene) are associated with coronary artery disease in elderly people. Thromb Haemost 1999; 82 suppl. 509 (abstract).
5 Moatti D, Seknadji P, Galand C, Poirier O, Fumeron F, Desprez S, Garbarz M, Dhermy D, Arveiler D, Evans A, Luc G, Ruidavets JB, Ollivier V, Hakim J, Aumont MC, de Prost D. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects. Impact of the V264M substitution on plasma levels of TFPI. Arterioscler Thromb Vasc Biol 1999; 19: 862-9.
6 Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry M-L, Fiesinger JN, Emmerich J, Aiach M. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 2000; 81: 193-7.